Bradbury Daniel's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Dec 1, 2023
- Accession no.
- 0001447362-23-000157
- Filed
- Dec 1, 2023
- Trade date
- Nov 29-30, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $593.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bradbury DanielCIK 0001236397 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | Common Stock | SSaleDisposed | −10,406 | $20.13F2 | −$209,472.78 | 86,788 | Indirect | |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −3,468 | $20.13F2 | −$69,810.84 | 60,197 | Indirect | |
| Nov 29, 2023 | Common Stock | SSaleDisposed | −3,468 | $20.13F2 | −$69,810.84 | 60,222 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −7,307 | $20.08F6 | −$146,724.56 | 79,481 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −2,436 | $20.08F6 | −$48,914.88 | 57,761 | Indirect | |
| Nov 30, 2023 | Common Stock | SSaleDisposed | −2,436 | $20.08F6 | −$48,914.88 | 57,786 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $20.010 to $20.320, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $20.000 to $20.245, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.